Christopher Amos

Last updated
Christopher Amos
Education Reed College
Louisiana State University Medical Center
Scientific career
Fields Genetic epidemiology
Institutions University of Texas MD Anderson Cancer Center
Geisel School of Medicine
Baylor College of Medicine
Thesis Robust methods for detection of genetic linkage for data from extended families and pedigrees (1988)
Doctoral advisor Robert C. Elston

Christopher Ian Amos is an American genetic epidemiologist and the director of the Institute for Clinical and Translational Research at Baylor College of Medicine, where he is also the associate director for quantitative science at the Dan L Duncan Comprehensive Cancer Center. [1] He is known for his research on the genetic basis of certain types of human cancer. [2] [3]

Contents

Biography

Amos was educated at Reed College, where he earned his undergraduate degree in mathematics in 1980, and at the Louisiana State University Medical Center, where he received his M.S. and Ph.D. degrees in 1985 and 1988, respectively. [4] He joined the Department of Epidemiology at the University of Texas MD Anderson Cancer Center in 1992, where he founded the Section of Computational and Genetic Epidemiology. In 2012, he was named the inaugural chair of the Department of Biomedical Data Science at the Geisel School of Medicine at Dartmouth College. He became director of the Institute for Clinical and Translational Research at Baylor College of Medicine on November 1, 2017, after being offered a $6 million "established investigator" grant by the Cancer Prevention and Research Institute of Texas. [1] [5]

Related Research Articles

<span class="mw-page-title-main">Baylor College of Medicine</span> Medical school in Houston, Texas

Baylor College of Medicine (BCM) is a medical school and research center in Houston, Texas, within the Texas Medical Center, the world's largest medical center. BCM is composed of four academic components: the School of Medicine, the Graduate School of Biomedical Sciences; the School of Health Professions, and the National School of Tropical Medicine.

The University of Texas Health Science Center at Houston (UTHealth) is a public academic health science center in Houston, Texas, United States. It was created in 1972 by The University of Texas System Board of Regents. It is located in the Texas Medical Center, the largest medical center in the world. It is composed of six schools: McGovern Medical School, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, UTHealth School of Dentistry, Cizik School of Nursing, UTHealth School of Biomedical Informatics and UTHealth School of Public Health.

The Institute of Biosciences and Technology (IBT), a component of the Texas A&M Health Science Center represents the Texas A&M University System, one of the two main Texas state university systems, in the state's and world's largest medical center, the Texas Medical Center, in Houston, Texas. The institute provides a bridge between Texas A&M University System scientists and other institutions' researchers working in the Texas Medical Center and the biomedical and biotechnology research community in Houston. It emphasizes collaboration between member scientists and others working in all the fields of the biosciences and biotechnology. IBT encourages its scientists to transfer discoveries made in their laboratories to the clinic and marketplace.

Malcolm K. Brenner is a British clinical scientist working mostly in the field of gene therapy and immunotherapy applied to malignancy. In 2016, Dr. Brenner was elected to the National Academy of Medicine, part of the National Academies of Sciences, Engineering, and Medicine.

<span class="mw-page-title-main">Hashem El-Serag</span>

Hashem B. El-Serag is a Palestinian-American physician and medical researcher best known for his research in liver cancer, hepatocellular carcinoma (HCC) and the hepatitis C virus. He serves as the Margaret M. and Albert B. Alkek Chairman of the Department of Medicine at Baylor College of Medicine as well as the Director of the Texas Medical Center Digestive Disease Center. El-Serag previously served as president of the American Gastroenterological Association and Editor-in-Chief of Clinical Gastroenterology and Hepatology.

<span class="mw-page-title-main">Edison Liu</span>

Edison T. Liu, M.D. is the former president and CEO of The Jackson Laboratory, and the former director of its NCI-designated Cancer Center (2012-2021). As CEO of The Jackson Laboratory, the organization doubled revenue, faculty and personnel, expanded globally from two campuses to six, established 13 endowed chairs, and increased the institutional endowment by five-fold. He is currently a Professor and Honorary Fellow at the institution. Before joining The Jackson Laboratory, he was the founding executive director of the Genome Institute of Singapore (GIS), chairman of the board of the Health Sciences Authority, and president of the Human Genome Organization (HUGO) (2007-2013). As the executive director of the GIS, he brought the institution to international prominence as one of the most productive genomics institutions in the world.

<span class="mw-page-title-main">Huda Zoghbi</span> Lebanese scientist

Huda Yahya Zoghbi, born Huda El-Hibri, is a Lebanese-born American geneticist, and a professor at the Departments of Molecular and Human Genetics, Neuroscience and Neurology at the Baylor College of Medicine. She is the director of the Jan and Dan Duncan Neurological Research Institute. She became the editor of the Annual Review of Neuroscience as of 2018.

The Center for Cell and Gene Therapy is a translational research institute within Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, all of which are located in the Texas Medical Center in Houston, Texas. The center's mission is to develop novel therapies for a range of diseases through collaboration between basic research laboratories and clinical departments. The center was founded by Dr. Malcolm K. Brenner in 1998 and includes six major parts. The current director is Dr. Helen E. Heslop, physician-scientist who specializes in translational research.

Helen Elisabeth Heslop is a physician-scientist from New Zealand whose clinical interests are in hematopoietic stem cell transplants. Heslop’s research focuses on immunotherapy to treat viral infections, post transplant and hematologic malignancies. She is a professor in the Department of Medicine and Pediatrics at Baylor College of Medicine and the director of the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital. She is also the Dan L. Duncan Chair and the associate director of clinical research at the Dan L. Duncan Cancer Center.

Daniel Albo is an American surgeon, medical researcher, and pioneer in minimally invasive gastrointestinal surgical oncology. He has published in areas including laparoscopic colorectal surgery and surgical oncology. He is the director of surgical oncology services and the director of health services research at the Georgia Regents University Cancer Center.

David John Sugarbaker was an American physician who was chief of the division of general thoracic surgery and the director of the Baylor College of Medicine Lung Institute at CHI St. Luke's Health–Baylor St. Luke's Medical Center in Houston, Texas. He was an internationally recognized thoracic surgeon specializing in the treatment of mesothelioma, the surgical management of malignant pleural mesothelioma, and treatment of complex thoracic cancers.

<span class="mw-page-title-main">Carl H. June</span> American immunologist and oncologist

Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.

<span class="mw-page-title-main">Andrea Ballabio</span> Italian scientist and academic professor

Andrea Ballabio, M.D., is an Italian scientist and academic professor. He is director of the Telethon Institute of Genetics and Medicine (TIGEM) of Pozzuoli; professor of medical genetics at the Federico II University of Naples and visiting professor of genetics at Baylor College of Medicine in Houston, Texas, US and at the University of Oxford-UK.

Robert Roberts, is a cardiologist, geneticist, speaker and educator, who is regarded as one of the founders of molecular cardiology, pioneering the genetic causes of heart disease

<span class="mw-page-title-main">Sharmila Anandasabapathy</span> Sri Lankan-American physician

Sharmila Anandasabapathy is a Sri Lankan-American physician and researcher in the field of gastrointestinal cancer. She is a professor of medicine in gastroenterology and serves as director of Baylor Global Health and vice president at the Baylor College of Medicine.

<span class="mw-page-title-main">James T. Willerson</span> American cardiologist (1939–2020)

James Thornton Willerson was an American cardiologist. He was the President Emeritus, Director of Cardiology Research, and Co-Director of the Cullen Cardiovascular Research Laboratories at the Texas Heart Institute. Upon moving to Houston in 1989, Willerson created the Institute of Molecular Medicine for the Prevention of Human Diseases.

<span class="mw-page-title-main">Joni L. Rutter</span> American geneticist

Joni L. Rutter is an American geneticist and the acting director of the National Center for Advancing Translational Sciences (NCATS). Rutter was previously director of the scientific programs in the All of Us initiative and served as the neuroscience and behavior division director at the National Institute on Drug Abuse. Her scientific experience includes clinical research in human genetics and environmental risk factors focusing on the fields of cancer and addiction.

Cheryl Lyn Walker is an American molecular biologist.

<span class="mw-page-title-main">Lindsey A. Criswell</span> American physician

Lindsey A. Criswell is an American rheumatologist and physician-scientist. She is director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Criswell was vice chancellor of research at University of California, San Francisco where she held the Jean S. Engleman Distinguished Professorship in Rheumatology.

Kathy J. Helzlsouer is an American oncologist, internist, and cancer epidemiologist who investigates cancer etiology and prevention, women's health, genetic counseling, and translational research. At the National Cancer Institute, she is the associate director of the epidemiology and genomics research program and chief medical officer for the division of cancer control and population sciences.

References

  1. 1 2 "Major Centers". Baylor College of Medicine. Retrieved 2019-06-23.
  2. Callaway, Ewen (2008-04-02). "Double-whammy gene keeps smokers hooked". New Scientist. Retrieved 2019-06-23.
  3. Park, Alice (2014-06-02). "BRCA breast cancer gene may also increase risk of lung cancer". Time. Retrieved 2019-06-23.
  4. "Chris Amos". Baylor College of Medicine. Retrieved 2019-06-23.
  5. Ackerman, Todd (2017-08-17). "Newest state cancer grants lure back former Houston research star". The Houston Chronicle. Retrieved 2019-06-23.